| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Medical Officer
1 company
Welgus Howard G. is a Director at Arcutis Biotherapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $989K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2025 | ARQT Arcutis Biotherapeutics, Inc. | - | Sell | 10,000 | $15.12 | $151,236.00 | -7.6% | -6.4% | +60.9% | |
| Mar 3, 2025 | ARQT Arcutis Biotherapeutics, Inc. | - | Sell | 10,000 | $13.00 | $130,048.00 | -7.0% | +5.1% | +83.9% | |
| Feb 3, 2025 | ARQT Arcutis Biotherapeutics, Inc. | - | Sell | 10,000 | $12.71 | $127,100.00 | -6.6% | +21.4% | +106.4% | |
| Jan 2, 2025 | ARQT Arcutis Biotherapeutics, Inc. | - | Sell | 10,000 | $14.67 | $146,714.00 | -6.2% | +14.0% | +99.2% | |
| Dec 2, 2024 | ARQT Arcutis Biotherapeutics, Inc. | - | Sell | 10,000 | $12.51 | $125,133.00 | -5.8% | +3.3% | +137.1% | |
| Nov 1, 2024 | ARQT Arcutis Biotherapeutics, Inc. | - | Sell | 10,000 | $8.65 | $86,541.00 | -5.5% | +57.7% | +191.9% | |
| Oct 1, 2024 | ARQT Arcutis Biotherapeutics, Inc. | - | Sell | 10,000 | $9.26 | $92,616.00 | -5.2% | +48.7% | +106.9% | |
| Sep 3, 2024 | ARQT Arcutis Biotherapeutics, Inc. | - | Sell | 10,000 | $10.77 | $107,695.00 | -5.0% | +18.2% | +51.8% | |
| Aug 1, 2024 | ARQT Arcutis Biotherapeutics, Inc. | - | Sale+OE | 10,000 | $9.87 | $98,696.00 | -2.7% | -10.1% | +50.7% | |
| Jul 1, 2024 | ARQT Arcutis Biotherapeutics, Inc. | - | Sale+OE | 10,000 | $9.31 | $93,141.00 | -5.3% | -2.7% | +43.8% |